CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 7 enrolled
Drug / intervention
Islet Transplantationdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00315588
NCT00315588Phase 2Completed
CompareCT.gov

Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation

Rodolfo Alejandro·interventional·Posted Apr 18, 2006·Updated Apr 12, 2017

In Brief

A Phase 2 clinical trial evaluating Islet Transplantation for Diabetes Mellitus, Type 1. Completed, enrolled 7 participants across 1 site.

Detailed Summary

The purpose of this study is to reverse hyperglycemia and insulin dependency, by islet cell transplantation, in patients with type 1 diabetes mellitus who have a stable kidney allograft.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 1
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), Health Resources and Services Administration (HRSA), Diabetes Research Institute Foundation, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

Phase 2CompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 18, 2006
Enrollment StartDec 1, 2000
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 13.4 yearsPosted 20.2 years ago

Interventions

Islet Transplantationdrug

Islet Transplantation in subjects with a previous kidney transplant.